Sentences with phrase «new immuno»

Apexigen is a clinical - stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for oncology, with an emphasis on new immuno - oncology agents that could harness the patient's immune system to combat and eradicate cancer.

Not exact matches

Bristol's $ 2.4 billion purchase of Medarex — which pharmaceutical analysts routinely cite as one of the best acquisitions in the history of the industry — would give the company not only a new blockbuster but also a leadership position in a burgeoning drug category: immuno - oncology.

Related Articles: Merck's Keytruda held back by docs who don't want to wait for diagnostics Bristol's Opdivo - Yervoy combo ups response rates in first - line lung cancer patients Roche's Tecentriq bursts onto immuno - oncology scene, with Merck and BMS in its sights Bristol - Myers» new Opdivo ad touts biomarker advantage over Merck's Keytruda Merck's Keytruda lines up its survival data for stepped - up battle with BMS» Opdivo

Pfizer says it will also make some new hires for immuno - oncology and gene therapy, two fields where it recently completed major deals.

Predicine has launched a new liquid biopsy panel called PredicineATLAS, which covers 600 genes and offers a readout of patients tumor mutational burden to help inform and assess immuno - oncology treatment.

Investigators have repeatedly touted the drug as a potential lynchpin in immuno - oncology, focusing on an enzyme that suppresses the immune cells Opdivo and a whole new class of PD - 1 / L1 checkpoints are designed to unleash in an attack on cancer cells.

For example, we've seen new discoveries in health care recently, especially in immuno - oncology therapies, which help the immune systems of cancer patients recognize and destroy cancerous cells.

Much current research in immuno - oncology focuses on improving these treatments, for example, by finding new immunotherapy targets and identifying biomarkers that predict a patient's response.

More precise application of immuno - therapies and the development of new approaches requires knowing the detailed immune landscape of individual patients and tumors.

This study tested a new combination therapy in immuno oncology and found encouraging response rates with omaveloxolone plus ipilimumab or nivolumab in patients who were checkpoint inhibitor naïve or resistant.

Seres Therapeutics, Inc. (NASDAQ: MCRB) today announced that new preclinical data supporting the development of microbiome therapeutics for immuno - oncology (leveraging gut microbiota to impact tumor immunotherapy) 1 will be presented today by Sceneay et al in the late breaking poster session at the 2018 American Association for Cancer Research Annual Meeting (AACR) in Chicago.

This can happen with chemo too, its nothing new, the cancer is trying to survive and usually when you do nt kill every cell, the strongest cells are the ones that survive and proliferate even faster, these cells are also not responsive to chemo / immuno anymore.

«We're gratified to deepen our relationship with AstraZeneca and MedImmune with this major initiative, and we look forward to getting underway immediately with our new joint immuno - oncology programs.»

Under the terms of the new agreement, AstraZeneca and Moderna, a pioneer of mRNA Therapeutics ™, have agreed to collaborate on two specific immuno - oncology programs, based on promising pre-clinical data, including pharmacology in tumor models.

This will fast - track new immune - modulating therapies for cancer patients by discovering and developing small molecule product candidates against immuno - oncology targets.

We're driving discovery research in immuno - oncology which is leading to new and exciting immunotherapeutic possibilities.

The CRI iAtlas database is the first comprehensive effort in immuno - oncology to address the recent National Cancer Moonshot Blue Ribbon Panel recommendation to establish a pan-cancer immune atlas that would help catalyze new research in cancer immunotherapy.

Having access to these powerful tools will accelerate getting new drugs and immuno - therapies to patients.

«Our internationally standardized, NGS - based LymphoTrack clonality assays with bioinformatics software provide a comprehensive solution in support of laboratories and pharmaceutical companies developing new drugs and immuno - therapies.

Co-engrafting mice with human tumors that retain the same characteristics and human immune cells, is a new platform to study the relationship between the human immune system and tumors and develop immuno - oncology - based cancer therapies.

U.S. Navy Naval Health Care New England (Newport, RI) 11/2001 — 11/2005 Advanced Medical Lab Technician • Served as the urinalysis work center supervisor responsible for the efficient processioning and reporting of patient samples • Successfully processed and reported approximately 13,500 patient samples without error • Performed a weekly rotation in hematology, microbiology, immuno - serology, and chemistry benches • Directed junior technicians setting workflow, schedules, and ensuring professional operations